Front. Cardiovasc. Med. Frontiers in Cardiovascular Medicine Front. Cardiovasc. Med. 2297-055X Frontiers Media S.A. 10.3389/fcvm.2023.1250733 Cardiovascular Medicine Correction Corrigendum: The association between higher FFAs and high residual platelet reactivity among CAD patients receiving clopidogrel therapy ZhaoZehao 1 2 3 DongShutong 1 2 3 SunTienan 1 2 3 HanKangning 1 2 3 HuangXin 1 2 3 MaMeishi 1 2 3 YangShiwei 1 2 3 * ZhouYujie 1 2 3 * Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China Beijing Institute of Heart, Lung and Blood Vessel Disease, Beijing, China Beijing Key Laboratory of Precision Medicine of Coronary Atherosclerotic Disease, Clinical Center for Coronary Heart Disease, Capital Medical University, Beijing, China

Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland

 Correspondence: Shiwei Yang jackydang@163.com Yujie Zhou azzyj12@163.com 11072023 2023 101250733 30062023 03072023 © 2023 Zhao, Dong, Sun, Han, Huang, Ma, Yang and Zhou. 2023Zhao, Dong, Sun, Han, Huang, Ma, Yang and Zhou

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

 free fatty acids (FFA) coronary artery disease clopidogrel platelet reactivity thromboelastogram percutaneous coronary intervention section-at-acceptanceGeneral Cardiovascular Medicine A Corrigendum on The association between higher FFAs and high residual platelet reactivity among CAD patients receiving clopidogrel therapy By Zhao Z, Dong S, Sun T, Han K, Huang X, Ma M, Yang S and Zhou Y. (2023) Front. Cardiovasc. Med. 10:1115142. doi: 10.3389/fcvm.2023.1115142

Incorrect Funding

In the published article, there was an error in the Funding statement. The correct Funding statement appears below.

FUNDING

This work was supported by grants from the National Key Research and Development Program of China (2017YFC0908800), Pilot Projects for Public Welfare Development of Beijing Municipal Medical Institute “Precise medicine and interventional diagnosis and treatment platform for coronary heart disease” (2019-3), Capital's Funds for Health Improvement and Research (CFH 2020-2-2063) and Beijing Municipal Natural Science Foundation (7202041).

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.